The upregulation of METTL3, an m6A writer, is also critical for the migration and invasion of CRC via its effects on miR-1246, whose downstream targets include the anti-oncogene SPRED2, which functions through the Raf/MEK/ERK pathway (Peng et al., 2019). The gene discussed is METTL3; the disease is colorectal carcinoma.